Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 62 (2) , 177-181
- https://doi.org/10.1016/0165-5728(95)00115-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Enumeration of T, B and Natural Killer Peripheral Blood Cells of Patients with Multiple Sclerosis and ControlsEuropean Neurology, 1992
- Natural killer cell number and activity in multiple sclerosisJournal of the Neurological Sciences, 1989
- Regulatory circuits in autoimmunity: recruitment of counter‐regulatory CD8+ T cells by encephalitogenic CD4+ T line cellsEuropean Journal of Immunology, 1988
- Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferonJournal of Neuroimmunology, 1988
- Fluctuations of CD4+ T‐cell subsets in remitting‐relapsing multiple sclerosisAnnals of Neurology, 1988
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987
- Human leukocyte IgG Fc receptorsImmunology Today, 1986
- Progressive multiple sclerosis: Abnormal immune functions in vitro and aberrant correlation with enumeration of lymphocyte subpopulationsJournal of Neuroimmunology, 1986
- Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2Clinical Immunology and Immunopathology, 1985
- Natural killer cells activity in patients with multiple sclerosis given α interferonAnnals of Neurology, 1983